Educational content only. This post explains how financial concepts and published data apply generally to healthcare practices — it does not constitute advice for your specific situation. Figures referenced are from published industry sources. Consult your accountant, lender, and relevant advisors before making any significant business or financial decisions.
Most independent clinic owners think about practice value once — when they're thinking about selling. The operators who end up with better outcomes are typically the ones who understood how it was calculated years earlier and built the practice accordingly.
This isn't about exit planning. It's about understanding what you're building. The valuation framework used for independent healthcare practices applies equally to a sale, to a lender's collateral assessment, to a partnership conversation, and to the question of whether the debt you're considering taking on to grow makes economic sense.
The EBITDA Multiple Framework
Published literature on healthcare practice transactions in both Canada and the United States consistently describes the EBITDA multiple method as the dominant valuation approach for independent clinical practices.
EBITDA — Earnings Before Interest, Taxes, Depreciation and Amortisation — is a measure of operating profitability before the effects of how the business is financed, its tax position, and non-cash accounting charges. For an owner-operated practice, published valuation resources in both countries describe a further adjustment: normalising the owner's compensation to a market-rate salary. This adjusted figure — sometimes called Seller's Discretionary Earnings (SDE) or normalised EBITDA — represents what the business earns as an economic entity, independent of how the owner chooses to pay themselves.
The multiple is applied to normalised EBITDA to arrive at an implied enterprise value. Published North American transaction databases and healthcare M&A advisory literature describe multiple ranges that vary by specialty, practice size, and specific characteristics. Published ranges span from approximately 2.0x to 10.0x or higher, with independent practice transactions most commonly described in the 2.5x–7.0x range in published North American sources.
The gap between 2.5x and 7.0x is substantial. On $200,000 of normalised EBITDA, the difference is $900,000. Understanding what drives a practice toward the top of that range versus the bottom is where the valuation conversation becomes strategically useful.
What Published Transaction Data Describes as Multiple Drivers
Owner dependency. Published valuation literature consistently identifies this as the single most significant multiple driver for independent practices. A practice where revenue is heavily concentrated in the owner — where referral relationships are personal, where patients come for the specific practitioner — presents a transition risk that buyers discount materially. Published data associates practices with associate coverage, documented referral sources, and transferable patient relationships with meaningfully higher multiples.
Revenue trend. Published M&A literature describes growing practices as attracting multiple premiums and declining practices as facing discounts — sometimes severe ones. The two to three years before any contemplated transaction are when revenue trajectory matters most to the valuation story.
Payer mix. Commercial insurance and private pay revenue is described in published transaction data as associated with higher multiples than heavy government payer dependence — reflecting higher revenue per visit, more predictable collection rates, and lower reimbursement risk. In Canada, provincial health billing is the government payer. In the US, Medicare and Medicaid are the primary government components. Published resources note that the impact varies by specialty.
Practice size and scalability. Larger multi-practitioner practices attract a broader buyer pool and command scale premiums in published transaction data. Solo practices face the smallest buyer pool and the largest key-person discount — which is structurally related to the owner dependency factor above.
Financial documentation quality. Published M&A resources from both markets consistently describe practices with CPA-prepared financial statements, clean separation of business and personal expenses, and documented revenue sources as attracting less due diligence discount. The documentation quality signals to a buyer that what they're seeing is accurate — and the absence of good documentation signals the opposite.
Enterprise Value vs. What You Actually Receive
The EBITDA multiple produces enterprise value — the implied total value of the business. What a seller actually receives is equity value: enterprise value minus outstanding debt obligations. A practice implied at $800,000 enterprise value with $300,000 of remaining loan balance has an equity value of $500,000 before transaction costs.
Deal structure adds another layer. Earnouts — where a portion of the purchase price is contingent on post-sale performance — are common in healthcare practice transactions, particularly where owner dependency is a factor. A headline price of $750,000 with $200,000 contingent on two years of post-sale revenue performance is a different financial outcome than $750,000 cash at closing.
Tax Treatment Differs Between Canada and the US
In Canada, published CRA documentation describes the Lifetime Capital Gains Exemption (LCGE) as potentially applicable to qualifying small business corporation share sales, subject to Qualified Small Business Corporation (QSBC) criteria. Published resources describe LCGE eligibility as something that requires planning — typically years before a transaction — and qualified tax advice specific to the seller's circumstances.
In the US, published tax resources describe long-term capital gains rates as applying to business interests held more than one year, with different treatments applying to different asset categories in an asset sale. The buyer preference for asset sales and seller preference for stock sales creates a structural tension in US transactions that published resources describe as frequently negotiated.
Both markets require qualified tax advice specific to the transaction and the seller's individual situation. This is one of the areas where general information — including this post — has the clearest limits.
→ See also: What Practice Valuation Multiples Actually Mean for Independent Operators
Generate an implied value range based on published North American transaction data for your specialty — with separate data for Canadian and US markets. Educational reference only, not an appraisal. A starting point for conversations with qualified advisors.
Explore Your Implied Range →Disclaimer: All financial figures and ranges referenced are from published industry sources and represent general patterns — not estimates for any specific practice. KlinDeck is not a financial advisor, accountant, lender, or lawyer. The tools referenced are educational references only. Consult qualified professionals before making significant business or financial decisions.